Daily non-political popular news in brief.

Fake antimalarial drugs analysis highlights threat to global health

A unique collaboration between scientists, public health workers and police has led to the arrest by the Chinese authorities of alleged traders of fake antimalarial drugs in southern China and the seizure of a large quantity of drugs. The work, involving teams from across the globe, has highlighted both the growing threat posed by fake pharmaceuticals and the complexities of tracking down those responsible for the trade.

Read more »

Keywords: fake, antimalarial, drugs, analysis, highlights, threat, global, health, drug, analysi, highlight

« Previous | Next »

Similar news on "Fake antimalarial drugs analysis highlights threat to global health":

1. New study looks at long-term drug costs for treating AIDS in Brazil
   11-12-2007 · EurekAlert!
   AIDS continues to be a staggering global public health problem. However, little is known about the long-term costs associated with providing drugs to AIDS patients in developing countries. To study those long-term cost trends, researchers from the Harvard School of Public Health have performed the first detailed analysis of AIDS drug cost trends in Brazil.
   Similar news · Read more »
   
2. Malaria product portfolio would benefit from greater cohesion amongst stakeholders
   10-03-2007 · EurekAlert!
   Malaria drug and vaccine research is booming. According to a report launched today in the UK byAustralian researchers at the George Institute for International Health, 16 new malaria vaccinecandidates are now in clinical trials; six new malaria drugs are about to reach the market; and by2011 we will have up to 12 new antimalarial drug product registered.
   Similar news · Read more »
   
3. Government's reliance on free market economics makes essential drug prices too high for the poor
   03-26-2007 · EurekAlert!
   Research in Malaysia, published in the latest PLoS Medicine, has established that drugs considered essential for adequate health care are often priced beyond the reach of the poorer members of society. It would cost, for example, three days wages for a low-paid government worker to buy a month’s supply of a commonly prescribed stomach ulcer pill.
   Similar news · Read more »
   
4. AGU journal highlights -- Sept. 6, 2007
   09-09-2007 · EurekAlert!
   Solving the mystery of booming sand dunes, South Asian monsoon shifts south since 1400, Ozone-destroying chemicals wane, Robotic probes improve ocean analysis, Universal rule for repeating earthquakes?, Abrupt climate change clues in tropical Africa, Antarctic ice cores record ancient meteoritic events, New angle on solar wind’s magnetic reconnections, Understanding permeability in sea ice, Global observations of large oceanic eddies, Magnetic reconnection at large and small scales, and Interhemispheric coupling between stratosphere and mesosphere are papers featured in the upcoming issue of Geophysical Research Letters.
   Similar news · Read more »
   
5. Health providers could save billions without compromising health care says drug study
   01-17-2007 · EurekAlert!
   Switching patients to more cost-effective drugs for cholesterol and blood pressure problems could reduce health budgets by billions without compromising clinical care, according to a study in the January issue of IJCP, the International Journal of Clinical Practice. No adverse events were reported after patients were switched -- the new cholesterol drugs delivered the same results as the previous drug and the new blood pressure drugs delivered improved performance.
   Similar news · Read more »
   
6. Geisinger scientist seeks cure for Lou Gehrig's disease, creating device to find treatment
   07-30-2007 · EurekAlert!
   Geisinger Health System researcher Glenn Gerhard is seeking a cure for a devastating neurodegenerative condition, amyotrophic lateral sclerosis, or Lou Gehrig's disease. A cure -- or perhaps a treatment -- might be found in the right mix of the millions of drugs and drug compounds developed in laboratories across the world. With the help of some college students, Gerhard is designing a device to efficiently test those compounds. And that's bringing us closer to a cure.
   Similar news · Read more »
   
7. The Journal of Clinical Pharmacology looks at effects of smoking cessation drug, 'Varenicline'
   10-31-2006 · EurekAlert!
   Smoking is the world's leading cause of premature death. Smokers who quit are able to significantly reduce their risk of premature death and other health issues -- almost completely if they quit by age thirty and by fifty percent if they quit after age fifty. Because it's so difficult to quit smoking, many are turning to smoking cessation drugs, such as varenicline, to help minimize cravings and other withdrawal symptoms.
   Similar news · Read more »
   
8. India's biotech industry emerging as world innovator, collaborator, competitor
   04-09-2007 · EurekAlert!
   India's health biotech firms are emerging as a major global player, with growing means and know-how to produce innovative as well as generic drugs and vaccines at costs small relative to those of giant Western firms, according to ground-breaking Canadian research being published Monday, April 9.
   Similar news · Read more »
   
9. Congressional proposals would cover all uninsured, reduce US health spending by up to $61B
   03-19-2007 · EurekAlert!
   A new analysis of health-reform bills in Congress prepared for the Commonwealth Fund Commission on a High Performance Health System shows that many current Congressional health-care proposals could significantly reduce the number of uninsured Americans and also decrease overall health-care expenditures including those for insurance administration and prescription drugs. The analysis finds that many of the plans would do more to cover uninsured Americans than the current Administration proposal.
   Similar news · Read more »
   
10. A gatekeeper for the US drug industry
    03-07-2007 · EurekAlert!
    At long last, the US is considering a government body, similar to the UK's National Institute for Health and Clinical Excellence (NICE), to review evidence on which drugs work well and whether they are cost-effective. The proposed Comparative Effectiveness Board (CEB) would review the pharmaceutical industry's hold on drug prices and stop it peddling mediocre medicines.
    Similar news · Read more »